1. Home
  2. LEXX vs NCRA Comparison

LEXX vs NCRA Comparison

Compare LEXX & NCRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • NCRA
  • Stock Information
  • Founded
  • LEXX 2004
  • NCRA 2002
  • Country
  • LEXX Canada
  • NCRA Taiwan
  • Employees
  • LEXX N/A
  • NCRA N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • NCRA Farming/Seeds/Milling
  • Sector
  • LEXX Health Care
  • NCRA Consumer Staples
  • Exchange
  • LEXX Nasdaq
  • NCRA Nasdaq
  • Market Cap
  • LEXX 16.5M
  • NCRA 15.1M
  • IPO Year
  • LEXX N/A
  • NCRA N/A
  • Fundamental
  • Price
  • LEXX $0.82
  • NCRA $1.68
  • Analyst Decision
  • LEXX Strong Buy
  • NCRA
  • Analyst Count
  • LEXX 1
  • NCRA 0
  • Target Price
  • LEXX $4.00
  • NCRA N/A
  • AVG Volume (30 Days)
  • LEXX 200.1K
  • NCRA 62.6K
  • Earning Date
  • LEXX 07-14-2025
  • NCRA 08-22-2025
  • Dividend Yield
  • LEXX N/A
  • NCRA N/A
  • EPS Growth
  • LEXX N/A
  • NCRA N/A
  • EPS
  • LEXX N/A
  • NCRA N/A
  • Revenue
  • LEXX $615,923.00
  • NCRA $16,647,379.00
  • Revenue This Year
  • LEXX $38.85
  • NCRA N/A
  • Revenue Next Year
  • LEXX $24.13
  • NCRA N/A
  • P/E Ratio
  • LEXX N/A
  • NCRA N/A
  • Revenue Growth
  • LEXX 49.85
  • NCRA N/A
  • 52 Week Low
  • LEXX $0.78
  • NCRA $0.70
  • 52 Week High
  • LEXX $4.38
  • NCRA $2.09
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 39.23
  • NCRA 75.11
  • Support Level
  • LEXX $0.82
  • NCRA $1.57
  • Resistance Level
  • LEXX $0.86
  • NCRA $1.78
  • Average True Range (ATR)
  • LEXX 0.07
  • NCRA 0.10
  • MACD
  • LEXX -0.01
  • NCRA 0.00
  • Stochastic Oscillator
  • LEXX 15.85
  • NCRA 74.63

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

About NCRA Nocera Inc.

Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.

Share on Social Networks: